Monthly Archives: April 2021

The CEO of AIkido Pharma (NASDAQ: AIKI) is Buying Shares

Today, the CEO of AIkido Pharma (AIKI – Research Report), Anthony Hayes, bought shares of AIKI for $9,900. This recent transaction increases Anthony Hayes’ holding in the company by 17.11% to a total of $69.11K. See today’s analyst top recommended

Friday’s Highlights at Noon: EKSO BIONICS (EKSO), Ocwen Financial (OCN), First Solar (FSLR), United States Steel (X), Tesla (TSLA)

So far Friday, April 30, NASDAQ is up 0.18% and the S&P is up 0.11%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; EKSO BIONICS (EKSO – Research Report), Ocwen Financial (OCN –

The Non-Executive of Generic Gold Corp. (Other OTC: GGCPF) is Buying Shares

Today, the Non-Executive of Generic Gold Corp. (GGCPF – Research Report), Victor Cantore, bought shares of GGCPF for $45.5K. This recent transaction increases Victor Cantore’s holding in the company by 5% to a total of $770.7K. In addition to Victor

The Chief Financial Officer of Fortuna Silver Mines (NYSE: FSM) is Buying Shares

Today, the Chief Financial Officer of Fortuna Silver Mines (FSM – Research Report), Luis Dario Ganoza Durant, bought shares of FSM for $245.3K. This is Durant’s first Buy trade following 11 Sell transactions. Following this transaction Luis Dario Ganoza Durant’s

Five9 (FIVN) Gets a Buy Rating from Needham

Needham analyst Scott Berg assigned a Buy rating to Five9 (FIVN – Research Report) today and set a price target of $200.00. The company’s shares closed last Thursday at $174.26. According to TipRanks.com, Berg is a top 25 analyst with

Needham Maintains Their Hold Rating on Gilead Sciences (GILD)

In a report released today, Joseph Stringer from Needham maintained a Hold rating on Gilead Sciences (GILD – Research Report). The company’s shares closed last Thursday at $63.84. According to TipRanks.com, Stringer is currently ranked with 0 stars on a